Breakout

Patentable Subject Matter: Pharmascience v Janssen

Are dosing regimens patentable? Do methods of medical treatment constitute patentable subject matter? What is an invention? This panel will discuss these questions and the highly anticipated decision from the Supreme Court of Canada in Pharmascience v Janssen. Hear from counsel for interveners about the issues at play before the Court and the potential implications of the decision in pharmaceutical patent litigation and beyond.

Andrew Skodyn Cassels Brock & Blackwell LLP (Toronto)
Bradley White Osler, Hoskin & Harcourt LLP (Ottawa)
Amy Grenon Tyr LLP (Toronto)
Moderator: Zarya Cynader Gilbert’s LLP (Toronto)